345 related articles for article (PubMed ID: 30953635)
1. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
[TBL] [Abstract][Full Text] [Related]
2. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
[TBL] [Abstract][Full Text] [Related]
3. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
Santella C; Renoux C; Yin H; Yu OHY; Azoulay L
Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457
[TBL] [Abstract][Full Text] [Related]
5. Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.
Oni OA; Dehkordi SHH; Jazayeri MA; Sharma R; Sharma M; Masoomi R; Sharma R; Gupta K; Barua RS
Am J Cardiol; 2019 Oct; 124(8):1171-1178. PubMed ID: 31409450
[TBL] [Abstract][Full Text] [Related]
6. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Safety of Testosterone-Replacement Therapy.
Lincoff AM; Bhasin S; Flevaris P; Mitchell LM; Basaria S; Boden WE; Cunningham GR; Granger CB; Khera M; Thompson IM; Wang Q; Wolski K; Davey D; Kalahasti V; Khan N; Miller MG; Snabes MC; Chan A; Dubcenco E; Li X; Yi T; Huang B; Pencina KM; Travison TG; Nissen SE;
N Engl J Med; 2023 Jul; 389(2):107-117. PubMed ID: 37326322
[TBL] [Abstract][Full Text] [Related]
8. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
[TBL] [Abstract][Full Text] [Related]
10. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men.
Siltari A; Murtola TJ; Kausz J; Talala K; Taari K; Tammela TL; Auvinen A
Acta Oncol; 2023 Dec; 62(12):1898-1904. PubMed ID: 37971326
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy and cardiovascular events.
Çatakoğlu AB; Kendirci M
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
[TBL] [Abstract][Full Text] [Related]
15. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
[TBL] [Abstract][Full Text] [Related]
16. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
[TBL] [Abstract][Full Text] [Related]
17. Chronic Testosterone Deprivation Sensitizes the Middle-Aged Rat Brain to Damaging Effects of Testosterone Replacement.
Smith C; Contreras-Garza J; Cunningham RL; Wong JM; Vann PH; Metzger D; Kasanga E; Oppong-Gyebi A; Sumien N; Schreihofer DA
Neuroendocrinology; 2020; 110(11-12):914-928. PubMed ID: 31671430
[TBL] [Abstract][Full Text] [Related]
18. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
19. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Morrison BF; Reid M; Madden W; Burnett AL
Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
